tiprankstipranks
Trending News
More News >
CNBX Pharmaceuticals (CNBX)
OTHER OTC:CNBX
US Market

CNBX Pharmaceuticals (CNBX) Ratios

Compare
122 Followers

CNBX Pharmaceuticals Ratios

CNBX's free cash flow for Q1 2026 was $0.00. For the 2026 fiscal year, CNBX's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
<0.01 <0.01 0.01 0.09 0.08
Quick Ratio
<0.01 <0.01 0.01 0.09 0.11
Cash Ratio
<0.01 <0.01 0.01 0.05 0.05
Solvency Ratio
-0.15 -0.12 -0.25 -1.41 -1.46
Operating Cash Flow Ratio
-0.07 -0.07 -0.10 -0.04 -0.69
Short-Term Operating Cash Flow Coverage
-0.14 -0.14 -0.19 -0.08 -0.95
Net Current Asset Value
$ -2.57M$ -2.50M$ -2.48M$ -2.29M$ -2.25M
Leverage Ratios
Debt-to-Assets Ratio
111.67 64.94 41.27 2.69 2.17
Debt-to-Equity Ratio
-0.48 -0.48 -0.52 -0.67 -1.08
Debt-to-Capital Ratio
-0.94 -0.92 -1.09 -1.99 13.91
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
>-0.01 >-0.01 -0.01 -0.25 -0.50
Debt Service Coverage Ratio
-0.22 -0.22 -0.46 -2.64 -2.03
Interest Coverage Ratio
-3.16 -6.76 -29.73 -793.34 -2.32K
Debt to Market Cap
134.74 26.42 6.91 9.01 0.42
Interest Debt Per Share
<0.01 0.01 0.04 0.15 1.44
Net Debt to EBITDA
-4.15 -4.32 -2.10 -0.34 -0.47
Profitability Margins
Gross Profit Margin
0.00%0.00%100.00%100.00%-562.68%
EBIT Margin
0.00%0.00%-519.70%-904.28%-12423.98%
EBITDA Margin
0.00%0.00%-463.58%-864.77%-11761.30%
Operating Profit Margin
0.00%0.00%-448.21%-227.07%-9860.37%
Pretax Profit Margin
0.00%0.00%-534.31%-904.57%-12428.23%
Net Profit Margin
0.00%0.00%-534.31%-904.57%-12581.02%
Continuous Operations Profit Margin
0.00%0.00%-534.31%-904.57%-14661.80%
Net Income Per EBT
100.00%100.00%100.00%100.00%101.23%
EBT Per EBIT
131.62%115.56%119.21%398.36%126.04%
Return on Assets (ROA)
-3523.95%-1702.97%-2214.57%-743.48%-464.64%
Return on Equity (ROE)
15.46%12.58%28.02%183.92%230.90%
Return on Capital Employed (ROCE)
11.62%10.88%23.51%46.17%180.97%
Return on Invested Capital (ROIC)
22.53%20.91%49.20%138.25%-2365.86%
Return on Tangible Assets
-3523.95%-1702.97%-2214.57%-743.48%-464.64%
Earnings Yield
-357.82%-692.73%-370.59%-2487.81%-90.67%
Efficiency Ratios
Receivables Turnover
0.00 0.00 26.19 4.34 0.00
Payables Turnover
0.00 0.00 0.00 0.00 0.43
Inventory Turnover
0.00 0.00 0.00 0.00 -2.46
Fixed Asset Turnover
0.00 0.00 0.00 1.49 0.07
Asset Turnover
0.00 0.00 4.14 0.82 0.04
Working Capital Turnover Ratio
0.00 0.00 -0.05 -0.18 -0.03
Cash Conversion Cycle
0.00 0.00 13.94 84.19 -996.31
Days of Sales Outstanding
0.00 0.00 13.94 84.19 0.00
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 -148.50
Days of Payables Outstanding
0.00 0.00 0.00 0.00 847.80
Operating Cycle
0.00 0.00 13.94 84.19 -148.50
Cash Flow Ratios
Operating Cash Flow Per Share
>-0.01 >-0.01 >-0.01 -0.01 -1.37
Free Cash Flow Per Share
>-0.01 >-0.01 >-0.01 -0.01 -1.37
CapEx Per Share
<0.01 0.00 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-44.91K 0.00 -204.24 -112.52K -1.01K
Capital Expenditure Coverage Ratio
-44.91K 0.00 -204.24 -112.52K -1.01K
Operating Cash Flow Coverage Ratio
-0.14 -0.14 -0.19 -0.08 -0.95
Operating Cash Flow to Sales Ratio
0.00 0.00 -1.88 -0.27 -56.05
Free Cash Flow Yield
-1294.49%-377.95%-130.89%-75.45%-40.43%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.19 -0.14 -0.27 -0.04 -1.10
Price-to-Sales (P/S) Ratio
0.00 0.00 1.44 0.36 138.76
Price-to-Book (P/B) Ratio
-0.03 -0.02 -0.08 -0.07 -2.55
Price-to-Free Cash Flow (P/FCF) Ratio
-0.05 -0.26 -0.76 -1.33 -2.47
Price-to-Operating Cash Flow Ratio
-0.41 -0.26 -0.77 -1.33 -2.48
Price-to-Earnings Growth (PEG) Ratio
>-0.01 <0.01 <0.01 <0.01 -0.03
Price-to-Fair Value
-0.03 -0.02 -0.08 -0.07 -2.55
Enterprise Value Multiple
-4.18 -4.48 -2.41 -0.38 -1.65
Enterprise Value
1.25M 1.23M 1.46M 1.36M 5.80M
EV to EBITDA
-4.19 -4.48 -2.41 -0.38 -1.65
EV to Sales
0.00 0.00 11.20 3.32 193.54
EV to Free Cash Flow
-6.97 -7.17 -5.93 -12.11 -3.45
EV to Operating Cash Flow
-6.97 -7.17 -5.96 -12.11 -3.45
Tangible Book Value Per Share
>-0.01 -0.03 -0.08 -0.23 -1.34
Shareholders’ Equity Per Share
>-0.01 -0.03 -0.08 -0.23 -1.34
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.00 -0.01
Revenue Per Share
0.00 0.00 <0.01 0.05 0.02
Net Income Per Share
>-0.01 >-0.01 -0.02 -0.42 -3.08
Tax Burden
1.00 1.00 1.00 1.00 1.01
Interest Burden
1.32 1.15 1.03 1.00 1.00
Research & Development to Revenue
0.00 0.00 1.50 1.05 39.50
SG&A to Revenue
0.00 0.00 3.99 2.18 58.57
Stock-Based Compensation to Revenue
0.00 0.00 1.07 0.44 24.33
Income Quality
0.46 0.55 0.35 0.03 0.45
Currency in USD